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Targeted gene regulation on a genome-wide scale
is a powerful strategy for interrogating, perturbing,
and engineering cellular systems. Here, we develop
a method for controlling gene expression based on
Cas9, an RNA-guided DNA endonuclease from
a type II CRISPR system.We show that a catalytically
dead Cas9 lacking endonuclease activity, when
coexpressed with a guide RNA, generates a DNA
recognition complex that can specifically interfere
with transcriptional elongation, RNA polymerase
binding, or transcription factor binding. This system,
which we call CRISPR interference (CRISPRi), can
efficiently repress expression of targeted genes in
Escherichia coli, with no detectable off-target
effects. CRISPRi can be used to repress multiple
target genes simultaneously, and its effects are
reversible. We also show evidence that the system
can be adapted for gene repression in mammalian
cells. This RNA-guided DNA recognition platform
provides a simple approach for selectively perturb-
ing gene expression on a genome-wide scale.
INTRODUCTION
The systematic interrogation of genomes and the genetic
reprogramming of cells require methods to precisely and
predictably target sets of genes for expression or repression.
RNA interference (RNAi) and engineered DNA-binding proteins
such as zinc finger or transcription-activator-like effector
(TALE) proteins, have emerged as powerful technologies fortargeted gene regulation (Hannon, 2002; Beerli and Barbas,
2002; Zhang et al., 2011). RNAi can be used in a relatively
straightforward manner to knock down expression of targeted
genes. RNAi, however, is limited to particular organisms that
have the proper host machinery and can sometimes exhibit
significant off-target effects and toxicity. In addition, custom
DNA-binding proteins, such as zinc finger or TALE proteins,
remain somewhat difficult and expensive to design, develop,
and empirically test in the cellular context (Klug, 2010). As
a consequence, it remains challenging to use DNA-binding
proteins for simultaneous modulation of multiple genes and
implementation of large-scale genetic programs.
The CRISPR (clustered regularly interspaced short palin-
dromic repeats) system provides a potential platform for
targeted gene regulation (Barrangou et al., 2007). About 40%
of bacteria and 90%of archaea possessCRISPR/CRISPR-asso-
ciated (Cas) systems to confer resistance to foreign DNA
elements (Makarova et al., 2011). CRISPR systems use small
base-pairing RNAs to target and cleave foreign DNA elements
in a sequence-specific manner (Wiedenheft et al., 2012). There
are diverse CRISPR systems in different organisms, and one of
the simplest is the type II CRISPR system from Streptococcus
pyogenes: only a single gene encoding the Cas9 protein and
two RNAs, a mature CRISPR RNA (crRNA) and a partially
complementary trans-acting RNA (tracrRNA), are necessary
and sufficient for RNA-guided silencing of foreign DNAs (Fig-
ure S1 available online) (Jinek et al., 2012; Gasiunas et al.,
2012). Maturation of crRNA requires tracrRNA and RNase III
(Deltcheva et al., 2011). However, this requirement can be by-
passed by using an engineered small guide RNA (sgRNA) con-
taining a designed hairpin that mimics the tracrRNA-crRNA
complex (Jinek et al., 2012). Base pairing between the sgRNA
and target DNA causes double-strand breaks (DSBs) due
to the endonuclease activity of Cas9. Binding specificity isCell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc. 1173
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Figure 1. Design of the CRISPR Interference System
(A) Theminimal interference system consists of a single protein and a designed
sgRNA chimera. The sgRNA chimera consists of three domains (boxed
region): a 20 nt complementary region for specific DNA binding, a 42 nt hairpin
for Cas9 binding (Cas9 handle), and a 40 nt transcription terminator derived
from S. pyogenes. The wild-type Cas9 protein contains the nuclease activity.
The dCas9 protein is defective in nuclease activity.
(B) The wild-type Cas9 protein binds to the sgRNA and forms a protein-RNA
complex. The complex binds to specific DNA targets by Watson-Crick base
pairing between the sgRNA and the DNA target. In the case of wild-type Cas9,
the DNA will be cleaved due to the nuclease activity of the Cas9 protein. We
hypothesize that the dCas9 is still able to form a complex with the sgRNA and
bind to specific DNA target. When the targeting occurs on the protein-coding
region, it could block RNA polymerase and transcript elongation.
See also Figure S1.determined by both sgRNA-DNA base pairing and a short DNA
motif (protospacer adjacent motif [PAM] sequence: NGG) juxta-
posed to the DNA complementary region (Marraffini and
Sontheimer, 2010). Thus, the CRISPR system only requires
a minimal set of two molecules—the Cas9 protein and the
sgRNA—and therefore holds the potential to be used as
a host-independent gene-targeting platform. Very recently, it
has been demonstrated that the Cas9/CRISPR can be har-
nessed for site-selective RNA-guided genome editing (Figure 1A)
(Mali et al., 2013; Cong et al., 2013; Jinek et al., 2013; Jiang et al.,
2013; Hwang et al., 2013; Cho et al., 2013).
To repurpose the Cas9/CRISPR for genome regulation
instead of genome editing, here we demonstrate that a catalyti-
cally inactive version of Cas9 can be repurposed as a platform
for RNA-guided transcription regulation. The transcription of
arbitrary genes can be modified by the mutant Cas9 without
genetically altering the target sequence (Figure 1B). To imple-
ment the system, we transferred the minimal Cas9/CRISPR
system from S. pyogenes to Escherichia coli (E. coli). Using
a modified Cas9 protein lacking endonucleolytic activity, we
generated an RNA-guided DNA recognition platform. Coexpres-
sion of the mutant Cas9 with an sgRNA designed with a 20 base1174 Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc.pair (bp) complementary region yields specific silencing of a
gene of interest without off-target effects. We call this modified
system CRISPR interference (CRISPRi). We show that CRISPRi
silencing occurs by blocking transcription and is highly efficient
with up to 1,000-fold repression. We characterize determinants
of the regulatory efficiency, including target loci, length, and
mismatches within the sgRNA base-pairing region. We also
show that multiple sgRNAs can be used simultaneously to regu-
late multiple genes. Furthermore, we demonstrate that the
CRISPRi system can be used to knock down endogenous genes
and to profile cis regulatory elements for transcription factor
binding in the lactose regulatory network. Finally, we show
that the CRISPRi system can also be used to knock down
gene expression in mammalian cells. The CRISPRi sequence-
specific targeting platform thus holds promise as a general
approach for modulating gene expression in a broad range of
host cells.
RESULTS
A Minimal CRISPRi System Consists of a Single Protein
and RNA and Can Effectively Silence Transcription
Initiation and Elongation
To implement such a CRISPRi platform in E. coli, we first ex-
pressed the wild-type S. pyogenes cas9 gene and an sgRNA
from bacterial vectors to determine whether it could perturb
gene expression at a targeted locus (Figure 2A). TheS. pyogenes
CRISPR system is orthogonal to the native E. coli system (Jinek
et al., 2012). The Cas9 protein is expressed from an anhydrote-
tracycline (aTc)-inducible promoter on a plasmid containing
a p15A replication origin, and the sgRNA is expressed from a
minimal constitutive promoter on a plasmid containing a ColE1
replication origin. Cas9 has been shown to have strong nuclease
activity. Thus, we expected that cotransformation of wild-type
Cas9 and an sgRNA that targets the E. coli genome would direct
double-stranded breaks at the target site (Mali et al., 2013; Jiang
et al., 2013). As an alternative strategy, we used a catalytically
dead Cas9 mutant (dCas9), which is defective in DNA cleavage,
hypothesizing that this form of Cas9 might still act as a simple
RNA-guided DNA-binding complex.
The sgRNAmolecules coexpressed with Cas9 each consist of
three segments: a 20 nucleotide (nt) target-specific complemen-
tary region, a 42 nt Cas9-binding hairpin (Cas9 handle), and
a 40 nt transcription terminator derived from S. pyogenes (Fig-
ure 2B). We constructed a red fluorescent protein (mRFP)-based
reporter system (Campbell et al., 2002) and inserted it into the
E. coli MG1655 genome.
Coexpression of the wild-type Cas9 protein and an sgRNA
(NT1) targeted to the mRFP coding sequence dramatically
decreased transformation efficiency (see Data S1 for sgRNA
sequences), likely due to Cas9-induced double-stranded breaks
on the genome (Figure S2A). Sequencing of a few survivor colo-
nies showed that they all had sequence rearrangements around
the target mRFP site on the genome, suggesting that there was
strong selection against expression of wild-type Cas9 and an
sgRNA targeted to a host sequence. The dCas9 mutant gene
(noncleaving), which contained two silencing mutations of
the RuvC1 and HNH nuclease domains (D10A and H841A)
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Figure 2. CRISPRi Effectively Silences Transcription Elongation and Initiation
(A) The CRISPRi system consists of an inducible Cas9 protein and a designed sgRNA chimera. The dCas9 contains mutations of the RuvC1 and HNH nuclease
domains. The sgRNA chimera contains three functional domains, as described in Figure 1.
(B) Sequence of designed sgRNA (NT1) and the DNA target. NT1 targets the nontemplate DNA strand of themRFP-coding region. Only the region surrounding the
base-pairing motif (20 nt) is shown. Base-pairing nucleotides are shown in orange, and the dCas9-binding hairpin is in blue. The PAM sequence is shown in red.
(C) CRISPRi blocks transcription elongation in a strand-specific manner. A synthetic fluorescence-based reporter system containing an mRFP-coding gene is
inserted into theE. coliMG1655 genome (the nsfA locus). Six sgRNAs that bind to either the template DNA strand or the nontemplate DNA strand are coexpressed
with the dCas9 protein, with their effects on the target mRFP measured by in vivo fluorescence assay. Only sgRNAs that bind to the nontemplate DNA strand
showed silencing (10- to 300-fold). The control shows fluorescence of the cells with dCas9 protein but without the sgRNA.
(D) CRISPRi blocks transcription initiation. Five sgRNAs are designed to bind to different regions around an E. coli promoter (J23119). The transcription start site is
labeled as +1. The dotted oval shows the initial RNAP complex that covers a 75 bp region from 55 to +20. Only sgRNAs targeting regions inside of the initial
RNAP complex show repression (P1–P4). Unlike transcription elongation block, silencing is independent of the targeted DNA strand.
(E) CRISPRi regulation is reversible. Both dCas9 and sgRNA (NT1) are under the control of an aTc-inducible promoter. Cell culture was maintained during
exponential phase. At time T = 0, 1 mMof aTcwas supplemented to cells with OD = 0.001. Repression of target mRFP starts within 10min. The fluorescence signal
decays in a way that is consistent with cell growth, suggesting that the decay is due to cell division. In 240 min, the fluorescence reaches the fully repressed level.
At T = 370min, aTc is washed away from the growthmedia, and cells are diluted back to OD = 0.001. Fluorescence starts to increase after 50min and takes about
300 min to rise to the same level as the positive control. Positive control: always without the inducer; negative control: always with 1 mM aTc inducer.
Fluorescence results in (C)–(E) represent average and SEM of at least three biological replicates. See also Figures S2 and S3.
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(Jinek et al., 2012), alleviated this lethality, as verified by transfor-
mation efficiency and E. coli growth rates (Figures S2A and S2B).
To test whether the dCas9:sgRNA complex could yield highly
efficient repression of gene expression, we designed sgRNAs
complementary to different regions of the mRFP coding
sequence, either binding to the template DNA strand or to the
nontemplate DNA strand. Our results indicated that sgRNAs tar-
geting the nontemplate DNA strand demonstrated effective gene
silencing (10- to 300-fold of repression), whereas those targeting
the template strand showed little effect (Figure 2C). The system
exhibited similar repression effects for genes that were within the
E. coli genome or on a high-copy plasmid (Figure S3). Further-
more, targeting to the promoter region also led to effective
gene silencing (Figure 2D). Targeting of the sgRNA to the 35
box significantly knocked down gene expression (P1, 100-
fold of repression), whereas targeting to other adjacent regions
showed a dampened effect (P2–P4). Targeting sequences about
100 bp upstream of the promoter showed no effects (P5). Unlike
targeting the coding sequence, when targeting the promoter,
the efficiency of silencing is independent of the DNA strand;
targeting of template or nontemplate strands is equally effective
(P2 and P3).
CRISPRi Gene Knockdown Is Inducible and Reversible
Unlike gene knockout methods, one advantage of using
CRISPRi-based knockdown of gene expression is the fact that
this perturbation should be reversible. To test whether CRISPRi
regulation could be induced and subsequently reversed, we en-
coded both dCas9 and mRFP-specific sgRNA (NT1) under the
control of the aTc-inducible promoter and performed time
course measurement of CRISPRi-mediated regulation of mRFP
in response to inducers (Figure 2E). At time zero, cell culture
that grew to the early exponential phase without inducers was
supplemented with 1 mM of aTc. Our data indicated that the
system could quickly respond to the presence of inducers—
the fluorescent reporter protein signal started to decrease within
10 min of the addition of the inducer molecule. Because the
mRFP protein is stable (Campbell et al., 2002), the rate of fluores-
cence signal decrease is limited by protein dilution due to cell
growth, as seen by a similar cell doubling time and loss of fluo-
rescence half-time (both 36 min). At 240 min, all cells were
uniformly repressed to the same level as the negative control.
At 370 min, the inducer was washed away from the growth
media, and cells were diluted back to a lower OD. After a delay
of 50 min, mRFP fluorescence started to increase. It took a total
300 min for single-cell fluorescence to increase to the same level
as the positive control. The 50 min delay is most likely deter-
mined by the dCas9/sgRNA turnover rate offset by dilution by
cell growth and division. In summary, these results demonstrate
that the silencing effects of dCas9-sgRNA can be induced and
reversed.
Native Elongating Transcript Sequencing Confirms
that CRISPRi Functions by Blocking Transcription
We hypothesized that dCas9 was functioning as an RNA-guided
DNA-binding complex that could block RNA polymerase (RNAP)
binding during transcription elongation. Because the non-
template DNA strand shares the same sequence identity as the1176 Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc.transcribed mRNA and only sgRNAs that bind to the non-
template DNA strand exhibited silencing, it remains a possibility
that the dCas9:sgRNA complex interacts with mRNA and alters
its translation or stability. To distinguish these possibilities,
we applied a recently described native elongating transcript
sequencing (NET-seq) approach to E. coli, which could be
used to globally profile the positions of elongating RNA polymer-
ases and monitor the effect of the dCas9:sgRNA complex on
transcription (Churchman and Weissman, 2011). In this NET-
seq method, we transformed the CRISPRi system into an
E. coli MG1655-derived strain that contained a FLAG-tagged
RNAP. The CRISPRi contained an sgRNA (NT1) that binds to
the mRFP-coding region. In vitro immunopurification of the
tagged RNAP followed by sequencing of the nascent transcripts
associated with elongating RNAPs allowed us to distinguish the
pause sites of the RNAP.
Our experiment demonstrated that the sgRNA induced strong
transcriptional pausing upstream of the sgRNA target locus (Fig-
ure 3A). The distance between the pause site and the target site
is 19 bp, which is in perfect accordance with the previously
reported 18 bp distance between the nucleotide incorporation
of RNAP and its front edge (Nudler et al., 1994). This finding is
consistent with a mechanism of CRISPRi in which the transcrip-
tion block is due to physical collision between the elongating
RNAP and the dCas9:sgRNA complex (Figure 3B). Binding of
the dCas9:sgRNA complex to the template strand had little
repressive effect, suggesting that RNAP was able to read
through the complex in this particular orientation. In this case,
the sgRNA faces the RNAP, which might be unzipped by the
helicase activity of RNAP. Though more structural studies are
required to provide a comprehensive understanding of the
system in vivo, we have demonstrated that CRISPRi utilizes
RNAs to directly block transcription. This mechanism is distinct
from that of RNAi, for which knockdown of gene expression
requires the destruction of already transcribed messenger
RNAs prior to their translation (Zamore et al., 2000).
CRISPRi sgRNA-Guided Gene Silencing Is Highly
Specific
To evaluate the specificity of CRISPRi on a genome-wide scale,
we performed whole-transcriptome shotgun sequencing (RNA-
seq) of dCas9-transformed cells with and without sgRNA coex-
pression (Figure 4A) (Mortazavi et al., 2008). In the presence of
the sgRNA targeted to mRFP (NT1), the mRFP transcript was
the sole gene exhibiting a decrease in abundance. No other
genes showed significant change in expression upon addition
of the sgRNA, within sequencing errors. We also performed
RNA-seq on cells with different sgRNAs that target different
genes. None of these experiments showed significant changes
of genes besides the targeted gene (Figure S4). Thus, sgRNA-
guided gene targeting and regulation are highly specific and do
not have significant off-target effects.
CRISPRi Can Be Used to Simultaneously Regulate
Multiple Genes
We next asked whether the CRISPRi system could allow control
of multiple genes independently without crosstalk. We devised
a dual-color fluorescence reporter system based on mRFP and
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Figure 3. CRISPRi Functions by Blocking Transcription Elongation
(A) FLAG-tagged RNAP molecules were immunoprecipitated, and the associated nascent mRNA transcripts were sequenced. (Top) Sequencing results of the
nascentmRFP transcript in cells without sgRNA. (Bottom) Results in cells with sgRNA. In the presence of sgRNA, a strong transcriptional pause is observed 19 bp
upstream of the target site, after which the number of sequencing reads drops precipitously.
(B) A proposed CRISPRi mechanism based on physical collision between RNAP and dCas9-sgRNA. The distance from the center of RNAP to its front edge is
19 bp, which matches well with our measured distance between the transcription pause site and 30 of sgRNA base-pairing region. The paused RNAP aborts
transcription elongation upon encountering the dCas9-sgRNA roadblock.sfGFP (Pe´delacq et al., 2006). Two sgRNAswith distinct comple-
mentary regions to each gene were designed. Expression of
each sgRNA only silenced the cognate gene and had no effect
on the other. Coexpression of two sgRNAs knocked down
both genes (Figures 4B and 4C). These results suggest that the
sgRNA-guided targeting is specific, with the specificity dictated
by its sequence identity, and is not impacted by the presence of
other sgRNAs. This behavior should enable multiplex control of
multiple genes simultaneously by CRISPRi.
Factors that Determine CRISPRi Silencing Efficiency
To find determinants of CRISPRi targeting efficiency, we investi-
gated the roles of length, sequence complementarity, and
position on silencing efficiency (Figure 5A). As suggested in Fig-
ure 2C, the location of the sgRNA target sequence along the
gene was important for efficiency. We further designed sgRNAs
to cover the full length of the coding regions for both mRFP and
sfGFP (see Data S1 for sgRNA sequences). In all cases, repres-
sion was inversely correlated with the target distance from the
transcription start site (Figure 5B). A strong linear correlation
was observed for mRFP. A similar but slightly weaker correlation
was observed when sfGFP was used as the target, perhaps indi-
cating varying kinetics of the RNA polymerase during different
points in elongation of this gene.
The sgRNA contains a 20 bp region that is complementary to
the target. To identify the importance of this base-pairing region,
we altered the length of sgRNA NT1 (Figure 5C). Whereas exten-
sion of the region from the 50 end did not affect silencing, trunca-
tion of the region severely decreased repression. The minimal
length of the base-pairing region needed for gene silencing
was 12 bp, with further truncation leading to complete loss of
function.We also introduced singlemutations into the base-pair-
ing region of sgRNA NT1 and tested how mismatches affected
overall silencing. From our results, three subregions could be
discerned, each with a distinct contribution to the overall bindingand silencing (Figure 5D). Importantly, any single mutation of the
first 7 nt dramatically decreased repression, suggesting that this
sequence constitutes a ‘‘seed region’’ for binding, as noted
previously for both the type I and type II CRISPR systems
(Wiedenheft et al., 2011; Jinek et al., 2012; Gasiunas et al.,
2012). We further mutated adjacent nucleotides in pairs (Figures
5E and S5). In most cases, the relative repression activity due
to a double mutation was multiplicative relative to the effects
of the single mutants, suggesting an independent relationship
between the mismatches. Furthermore, in agreement with
previous results on the importance of the PAM sequence, an
incorrect PAM totally abolished silencing even with a 20 bp
perfect binding region (Figure 5E). Thus, we conclude that the
specificity of the CRISPRi system is determined jointly by the
PAM (2 bp) and at least a 12 bp sgRNA-DNA stretch, the space
of which is large enough to cover most bacterial genomes for
unique target sites.
We tested whether the efficiency of CRISPRi could be
enhanced by using two sgRNAs both targeted against the
same gene (Figures 5F and S6). Depending on the relative posi-
tioning of multiple sgRNAs, we observed distinct combinatorial
effects. Combining two sgRNAs—each with about 300-fold
repression—allowed us to increase the overall silencing to up
to 1,000-fold. Combining two weaker sgRNAs (5-fold) showed
multiplicative effects when used together. We also observed
suppressive combinatorial effects using two sgRNAs whose
targets overlapped. This was probably due to competition of
both sgRNAs for binding to the same region.
Interrogating an Endogenous Regulatory Network Using
CRISPRi Gene Knockdown
We next tested whether the CRISPRi system could be used as
a gene knockdown platform to interrogate endogenous gene
networks. Previous methods to interrogate microbial gene
networks have mostly relied on laborious and costly genomicCell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc. 1177
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Figure 4. Targeting Specificity of the CRISPRi System
(A) Genome-scale mRNA sequencing (RNA-seq) confirms that CRISPRi targeting has no off-target effects. The sgRNA NT1 that binds to the mRFP coding region
is used. The dCas9, mRFP, and sfGFP genes are highlighted.
(B) Multiple sgRNAs can independently silence two fluorescent protein reporters in the same cell. Each sgRNA specifically represses its cognate gene, but not the
other gene. When both sgRNAs are present, both genes are silenced. Error bars represent SEM from at least three biological replicates.
(C) Microscopic images for using two sgRNAs to control two fluorescent proteins. (Top) Bright-field images of the E. coli cells; (middle) RFP channel; (bottom)
GFP channel. Coexpression of one sgRNA and dCas9 only silences the cognate fluorescent protein, but not the other. The knockdown effect is strong, as
almost no fluorescence is observed from cells with certain fluorescent protein silenced. Scale bar, 10 mm. Control shows cells without any fluorescent protein
reporters.
Fluorescence results represent average and SEM of at least three biological replicates. See also Figure S4.engineering and knockout procedures. By contrast, gene knock-
down with CRISPRi requires only the design and synthesis of
a small sgRNA bearing a 20 bp complementary region to the
desired genes. To demonstrate this, we applied CRISPRi to
create E. coli knockdown strains by designing sgRNAs (see
Data S1 for sgRNA sequences) to systematically perturb genes
that were part of the well-characterized E. coli lactose regulatory
pathway (Figure 6A). We performed b-galactosidase assays to
measure LacZ expression from the knockdown strains, with
and without isopropyl b-D-1-thiogalactopyranoside (IPTG),
a chemical that inhibits the lac repressor (LacI) (Lewis, 2005).
In wild-type cells, addition of IPTG induced LacZ expression.
Our results showed that a lacZ-specific sgRNA could strongly
repress LacZ expression (Figure 6B). Conversely, an sgRNA tar-
geting the lacI gene led to activation of LacZ expression even in
the absence of IPTG, as would be expected for silencing a direct
repressor of LacZ expression.
It is known that cAMP-CRP is an essential activator of LacZ
expression by binding to a cis regulatory site upstream of the
promoter (A site). Consistently, the sgRNA that was targeted to
the crp gene or to the A site in the LacZ promoter led to repres-
sion, demonstrating a means to link a regulator to its cis-regula-
tory sequence using CRISPRi experiments. Targeting the adeny-
late cylase gene (cya), which is necessary to produce the cAMP
that makes CRP more effective at the LacZ promoter, only led to
partial repression. Addition of 1 mM cAMP to the growth media
complemented the effects for cya knockdown, but not for crp
knockdown, suggesting that cya is an indirect regulator of
LacZ. Furthermore, targeting the LacI cis-regulatory site (O
site) with an sgRNA led to inhibition, presumably because
Cas9 complex binding at this site sterically blocks RNA poly-1178 Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc.merase, mimicking the behavior of the LacI transcription
repressor. Targeting the known RNAP-binding site (P site) also
blocked expression. In summary, these studies demonstrate
that the CRISPRi-based gene knockdown method provides
a rapid and effective approach for interrogating the regulatory
functions (activating or repressing) of genes and cis elements
in a complex regulatory network (Figure 6C).
CRISPRi Can Knock Down Targeted Gene Expression in
Human Cells
To test the generality of the CRISPRi approach for using the
dCas9-sgRNA complex to repress transcription, we tested the
system in the HEK293 mammalian cells. The dCas9 protein
was codon optimized, fused to three copies of a nuclear local-
ization sequence (NLS), and expressed from a murine stem
cell virus (MSCV) retroviral vector. The same sgRNA design
shown in Figure 2B was used to express sgRNAs from the
RNA polymerase III U6 promoter. A reporter HEK293 cell line
expressing EGFP under the SV40 promoter was created by viral
infection. Using an sgRNA (eNT2) that targeted the nontemplate
DNA strand of the EGFP-coding region (see Data S1 for sgRNA
sequences), we observed moderate but reproducible knock-
down of gene expression (46% repression; Figure 7A). The
repression is dependent on both the dCas9 protein and sgRNA,
implying that repression is due to the dCas9-sgRNA complex
and RNA-guided targeting. The same sgRNA exhibited better
repression on the same gene when transiently expressed from
a plasmid (63% repression; Figure S7). Consistent with the
bacterial system, only sgRNAs targeted to the nontemplate
strand exhibited repression. The regulatory effects in mamma-
lian cells, however, appear to be more dependent on the
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Figure 5. Characterization of Factors that Affect Silencing Efficiency
(A) We measured the silencing effects of sgRNAs with different targeting loci on the same gene (distance from the translation start codon) and sgRNAs with
different lengths of the base-pairing region to the same target locus (based on NT1).
(B) The silencing efficiency is inversely correlated with the target distance from the translation start codon (orange, mRFP; green, sfGFP). The relative repression
activity is calculated by normalizing repression of each sgRNA to that of the sgRNA with the highest repression fold change. Error bars represent SEM from three
biological replicates.
(C) The length of the Watson-Crick base-pairing region between the sgRNA and the target DNA affects repression efficiency. Extensions of the base-pairing
region all exhibit strong silencing effect, and truncations dramatically decrease repression. The minimal length of the base-pairing region for detectable
repression is 12 bp. Error bars represent SEM from three biological replicates.
(D) We introduced single mismatches into every nucleotide on sgRNA (NT1; Figure 2B) and measured how single mismatches affect repression efficiency. Three
subregions with distinct importance to the overall silencing can be discerned. They show a step function. The first 7 nt region is critical for silencing and likely
constitutes a ‘‘seed’’ region for probing sgRNAs binding to the DNA target. The PAMsequence (NGG) is indispensible for silencing. Error bars represent SEM from
three biological replicates.
(E) Silencing effects of sgRNAs with adjacent double mismatches. The relative repression activity of single-mismatched sgRNAs is shown in gray, with the
mismatch position labeled on the bottom. Experimentally measured activity of double-mismatched sgRNAs is shown in blue. Calculated activity by multiplying
the effects of two single-mismatched sgRNAs is shown in white and labeled with ‘‘Com.’’ In most cases, the silencing activity of a double-mismatched sgRNA is
simply a multiplication of the activities of single-mismatched sgRNAs (except Figure S5B), suggesting an independent relationship between single mismatches.
Error bars represent SEM from three biological replicates.
(F) Combinatorial silencing effects of using double sgRNAs to target a single mRFP gene. Using two sgRNAs that target the same gene, the overall knockdown
effect can be improved to almost 1,000-fold. When two sgRNAs bind to nonoverlapping sequences of the same gene, repression is augmented. When two
sgRNAs target overlapping regions, repression is suppressed. Error bars represent SEM from three biological replicates.
Fluorescence results represent average and SEM of at least three biological replicates. See also Figures S5 and S6.targeting locus, as only two out of seven tested sgRNAs
showed moderate repression (Figure 7B). Factors such as the
distance from the transcription start and the local chromatin
state may be critical parameters in determining repression effi-ciency (Figure S7). Optimization of dCas9 and sgRNA expres-
sion, stability, nuclear localization, and interaction will likely
allow for further improvement of CRISPRi efficiency in mamma-
lian cells.Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc. 1179
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Figure 6. Functional Profiling of a Complex
Regulatory Network Using CRISPRi Gene
Knockdown
(A) sgRNAs are designed and used to knock down
genes (cya, crp, lacI, lacZ, lacY, and lacA) in the
lac regulatory pathway or block transcriptional
operator sites (A/P/O). LacI is a repressor of the
lacZYA operon by binding to a transcription
operator site (O site). The lacZ gene encodes an
enzyme that catalyzes lactose into glucose. A few
trans-acting host genes such as cya and crp are
involved in the activation of the lacZYA system.
The cAMP-CRP complex binds to a transcription
operator site (A site) and recruits RNA polymerase
binding to the P site, which initiates transcription
of lacZYA. IPTG, a chemical that inhibits LacI
function, induces LacZ expression.
(B) b-galactosidase assay of the knockdown
strains without (white) and with (gray) IPTG.
Control shows that the wild-type cells without
CRISPRi perturbation can be induced by addition
of IPTG. The sgRNA that targets LacZ strongly
represses LacZ expression even in the presence
of IPTG. When LacI is targeted, LacZ expression
is high even without IPTG. Targeting cya and crp
genes leads to decreased LacZ expression level
in the presence of IPTG. Presence of 1mM cAMP
rescues cya knockdown, but not crp knockdown.
Blocking the transcription operator sites results in
LacZ repression, suggesting that these are
important cis-acting regulatory sites for LacZ.
Upon perturbation, decreased (red arrows) and
increased (green arrows) expression of LacZ are
indicated. Error bars represent SEM from three
biological replicates.
(C) The knockdown experiments allow us to
profile the roles of regulators in the lac regulatory
circuit. The data is shown on a two-dimensional
(2D) graph, with x axis showing LacZ activity
without IPTG and y axis showing its activity with
IPTG. The spreading of ovals along each axis
shows the SEM of three biological replicates.
The b-galactosidase assay results represent
average and SEM of three biological replicates.
For RNA-seq data on LacI and LacZ targeting, see
also Figure S4.DISCUSSION
CRISPRi Efficiently and Selectively Represses
Transcription of Target Genes
The CRISPRi system that we report here is a relatively simple
platform for targeted gene regulation. CRISPRi does not rely
on the presence of complex host factors but instead only
requires the dCas9 protein and guide RNAs and thus is flexible
and highly designable. Our results have demonstrated that the
system can efficiently silence genes in bacteria. The silencing
is very specific; we observe no detectable off-target effects.
Furthermore, the efficiency of the knockdown can be tuned by
changing the target loci and the degree of base pairing between
the sgRNA and the target gene. This will make it possible to1180 Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc.create allelic series of hypomorphs, a feature that will be espe-
cially useful for the study of essential genes. The system func-
tions by directly blocking transcription in a manner that can be
easily programmed by designing sgRNAs. To our knowledge,
this is one of the first examples of utilizing a targeted protein-
RNA complex that directly blocks transcription elongation within
protein-coding regions. Mechanistically, this is distinct from
RNAi-based silencing, which requires the destruction of already
transcribed mRNAs.
In addition, these dCas9:sgRNA complexes can also
modulate transcription by targeting key cis-acting motifs within
any promoter, sterically blocking the association of their
cognate trans-acting transcription factors. Thus, in addition to
its use as a gene knockdown tool, CRISPRi could be used for
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Figure 7. CRISPRi Can Repress Gene
Expression in Human Cells
(A) A CRISPRi system in HEK293 cells. The SV40-
EGFP expression cassette is inserted into the
genome via retroviral infection. The dCas9 protein
is codon-optimized and fused with three copies of
NLS sequence. The sgRNA is expressed from an
RNA polymerase III U6 vector. Cotransfection of
dCas9 and an sgRNA (eNT2) that targets the
nontemplate DNA strand of EGFP decreases
fluorescence (46%), whereas the expression of
either dCas9 or sgRNA alone shows no effect.
(B) The dCas9:sgRNA-mediated repression is
dependent on the target loci. Seven sgRNAs are
designed to target different regions of the EGFP-
coding sequence on the template or nontemplate
strand. Only eNT2 and eNT5 show moderate
repression. EGFP fluorescence (targeted reporter)
is shown in green, whereas mCherry fluorescence
(control reporter) is shown in pink.
Fluorescence results from (A) and (B) represent
average and error of two biological replicates. See
also Figure S7.functional mapping of promoters and other genomic regulatory
modules.
CRISPRi Is Amenable to Genome-Scale Analysis
and Regulation
The CRISPRi method is based on the use of sgRNAs, and only
the 20 bp matching region needs to be designed for specific
gene targets. With the advances of large-scale DNA oligonucle-
otide synthesis technology, generating large sets of oligonucle-
otides that contain unique 20 bp regions for genome targeting
is fast and inexpensive. These oligonucleotide libraries could
potentially allow us to target large numbers of individual genes
to infer gene function or to target gene pairs tomap genetic inter-
actions. Furthermore, CRISPRi could be used to simultaneously
modulate the expression of large sets of genes, as the small size
of sgRNAs allows one to concatenate multiple elements into the
same expression vector (Qi et al., 2012).
CRISPRi Provides Tools for Manipulating Microbial
Genomes
Because the CRISPRi platform is compact and self-contained,
it has the potential to be adapted for different organisms.
CRISPRi could thus be a powerful tool for studying nonmodel
organisms for which genetic engineering methods are not
well developed, including pathogens or industrially useful organ-
isms. Unlike most eukaryotes, most bacteria lack the RNAi
machinery. As a consequence, regulation of endogenous genes
using designed synthetic RNAs is currently limited. CRISPRi
could provide an RNAi-like method for gene perturbation in
microbes.Cell 152, 1173–1183, FCRISPRi as a Platform for
Engineering Transcriptional
Regulatory Networks
The CRISPRi has the potential to be
utilized as a flexible framework for engi-neering transcriptional regulatory networks. Because it is
essentially an RNA-guided DNA-binding complex, the CRISPRi
platform also provides a potentially flexible scaffold for directing
diverse regulatory machinery to specific sites in the genome.
Beyond simply blocking transcription of target genes, it may
be possible to couple the dCas9 protein with numerous regula-
tory domains to modulate different biological processes and
to generate different functional outcomes (e.g., transcriptional
activation and chromatin modifications).
While our paper was under review, several very recent studies
reported the use of wild-type Cas9/CRISPR for targeted genome
editing in diverse organisms (Mali et al., 2013; Cong et al.,
2013; Jinek et al., 2013; Jiang et al., 2013; Hwang et al., 2013;
Cho et al., 2013). Different engineered forms of the CRISPR plat-
forms can address complementary applications. The wild-type
CRISPR system with its endogenous nuclease activity is ideal
for targeted modification of genome sequences such as gene
mutagenesis, deletion, and insertion. In contrast, the CRISPRi
system reported here, based on the catalytically dead Cas9, is
ideal for targeted gene regulation such as transcription repres-
sion and activation without altering the target sequence.
In the CRISPRi system, it may also be possible to link multiple
sgRNAs into transcriptional circuits in which one upstream
sgRNA controls the expression of a different downstream sgRNA
(Lucks et al., 2011). As RNAmolecules inmicroorganisms tend to
be short-lived, we suspect that the genetic programs regulated
by sgRNAs might show rapid kinetics distinct from circuits that
involve slow processes such as protein expression and degrada-
tion. Furthermore, the sgRNAs can also act as inputs to control
arbitrary genes in the genome, thus providing a way to directlyebruary 28, 2013 ª2013 Elsevier Inc. 1181
interface with the host genome without altering the target
sequence.
In summary, the CRISPRi system holds great promise as
a general genetic programming platform that is suitable for
a variety of biomedical research and clinical applications,
including genome-scale functional profiling, microbial metabolic
engineering, and cell reprogramming.
EXPERIMENTAL PROCEDURES
Strains and Media
The Escherichia coli (E. coli) K-12 strain MG1655 was used as the host strain
for the in vivo fluorescence measurements. An E. coli MG1655-derived
strain that endogenously expresses a variant of RNAPwith a 33 FLAG epitope
tag attached to the C-terminal end of the RpoC subunit was used for all
NET-sequencing experiments. EZ-rich defined media (EZ-RDM, Teknoka)
was used as the growth media for in vivo fluorescence assays. Genetic trans-
formation and verification of transformationwere done as previously described
(Qi et al., 2012), using AmpR, CmR, or KanR genes as selectable markers.
Plasmid Construction and E. coli Genome Cloning
TheCas9 and dCas9 geneswere cloned from the previously described vectors
pMJ806 and pMJ841, respectively (Jinek et al., 2012). The genes were PCR
amplified and inserted into a vector containing an aTc-inducible promoter
PLtetO-1 (Lutz and Bujard, 1997), a chloramphenicol-selectable marker, and
a p15A replication origin. The sgRNA template was cloned into a vector con-
taining a minimal synthetic promoter (J23119) with an annotated transcrip-
tion start site, an ampicillin-selectable marker, and a ColE1 replication origin
(see Data S1 for sgRNA sequences). Inverse PCR was used to generate
sgRNA cassettes with new 20 bp complementary regions. To insert fluores-
cent reporter genes into E. coli genomes, the fluorescent gene was first
cloned onto an entry vector, which was then PCR amplified to generate
linearized DNA fragments that contained nsfA 50/30 UTR sequences, the
fluorescent gene, and a KanR-selectable marker. The E. coli MG1655 strain
was transformed with a temperature-sensitive plasmid pKD46 that contained
l-Red recombination proteins (Exo, Beta, and Gam) (Wang et al., 2009). Cell
cultures were grown at 30C to an OD (600 nm) of 0.5, and 0.2% arabinose
was added to induce expression of the l-Red recombination proteins for 1 hr.
The cells were harvested at 4C and were used for transformation of the line-
arized DNA fragments by electroporation. Cells that contain correct genome
insertions were selected by using 50 mg/ml kanamycin.
Flow Cytometry and Analysis
Strains were cultivated in EZ-RDM containing 100 mg/ml carbenicillin and
34 mg/ml chloramphenicol in 2 ml 96-well deep well plates (Costar 3960) over-
night at 37C and 1200 rpm. 1 mL of this overnight culture was then added
to 249 ml of fresh EZ-RDM with the same antibiotic concentrations, with 2 mM
aTc supplemented to induce production of the dCas9 protein. When cells
were grown to midlog phase (4 hr), the levels of fluorescence protein were
determined using the LSRII flow cytometer (BD Biosciences) equipped with
a high-throughput sampler. Cellswere sampledwith a lowflow rate until at least
20,000 cells had been collected. Data were analyzed using FCS Express (De
NovoSoftware) by gating on a polygonal region containing 60%cell population
in the forward scatter-side scatter plot. For each experiment, triplicate cultures
were measured, and their standard deviation was indicated as the error bar.
b-Galactosidase Assay
To perform b-galactosidase assay, we added 1 ml of overnight culture
prepared as above to 249 ml of fresh EZ-RDMwith the same antibiotic concen-
trations with 2 mM aTc, with or without 1 mM IPTG. Cells were grown to midlog
phase. The LacZ activity of 100 ul of this culture wasmeasured using the yeast
b-galactosidase assay kit (Pierce) following the instructions.
Extraction and Purification of Total RNA
For each sample, a monoclonal culture of E. coli was grown at 37C from an
OD (600 nm) 0.1 in 500 ml of EZ-RDM to early logphase (OD 0.45 ± 0.05), at1182 Cell 152, 1173–1183, February 28, 2013 ª2013 Elsevier Inc.which point the cells were harvested by filtration over 0.22 mm nitrocellulose
filters (GE) and frozen in liquid nitrogen to simultaneously halt all transcriptional
progress. Frozen cells (100 mg) were pulverized on a QIAGEN TissueLyser II
mixer mill six times at 15 Hz for 3 min in the presence of 500 ml frozen lysis
buffer (20 mM Tris [pH 8], 0.4% Triton X-100, 0.1% NP-40, 100 mM NH4Cl,
50U/ml SUPERase,In (Ambion), and 13 protease inhibitor cocktail (Complete,
EDTA-free, Roche), supplemented with 10 mMMnCl2 and 15 mMTagetin tran-
scriptional inhibitor (Epicenter).
The lysate was resuspended on ice by pipetting. RQ1 DNase I (110 U total,
Promega) was added and incubated for 20 min on ice. The reaction was
quenched with EDTA (25 mM final) and the lysate clarified at 4C by centrifu-
gation at 20,000 3 g for 10 min. The lysate was loaded onto a PD MiniTrap
G-25 column (GE Healthcare) and eluted with lysis buffer supplemented with
1 mM EDTA.
Total mRNA Purification
Total RNA was purified from the clarified lysate using the miRNeasy kit
(QIAGEN). 1 mg of RNA in 20 ml of 10 mM Tris (pH 7) was mixed with an equal
volume of 23 alkaline fragmentation solution (2 mM EDTA, 10 mM Na2CO3,
and 90 mM NaHCO3 [pH 9.3]) and incubated for 25 min at 95C to generate
fragments ranging from 30 to 100 nt. The fragmentation reaction was stopped
by adding 0.56 ml of ice-cold precipitation solution (300 mM NaOAc [pH 5.5]
plus GlycoBlue [Ambion]), and the RNAwas purified by a standard isopropanol
precipitation. The fragmented mRNA was then dephosphorylated in a 50 ml
reaction with 25 U T4 PNK (NEB) in 13 PNK buffer (without ATP) plus 0.5 U
SUPERase,In, and precipitated with GlycoBlue via standard isopropanol
precipitation methods.
Nascent RNA Purification
For nascent RNA purification, we added the clarified lysate to 0.5 ml anti-FLAG
M2 affinity gel (SigmaAldrich) as described previously (Churchman andWeiss-
man, 2011). The affinity gel was washed twice with lysis buffer supplemented
with 1mMEDTA before incubationwith the clarified lysate at 4C for 2.5 hr with
nutation. The immunoprecipitation was washed 4 3 10 ml with lysis buffer
supplemented with 300 mM KCl, and bound RNAP was eluted twice with lysis
buffer supplemented with 1 mM EDTA and 2 mg/ml 33 FLAG peptide (Sigma
Aldrich). Nascent RNA was purified from the eluate using the miRNeasy kit
(QIAGEN) and was converted to DNA using a previously established library
generation protocol (Churchman and Weissman, 2011).
DNA Library Preparation and DNA Sequencing
The DNA library was sequenced on an Illumina HiSeq 2000. Reads were pro-
cessed using the HTSeq Python package, and other custom software written
in Python. The 30 end of the sequenced transcript was aligned to the reference
genome using Bowtie (http://bowtie-bio.sourceforge.net/) and the RNAP
profiles were generated in MochiView (http://johnsonlab.ucsf.edu/mochi.
html).
Plasmid Design and Construction for CRISPRi in Human Cells
The sequence encoding mammalian-codon-optimized Streptococcus
pyogenes Cas9 (DNA 2.0) was fused with three C-terminal SV40 nuclear local-
ization sequences (NLS) or to tagBFP flanked by two NLS. Using standard
ligation-independent cloning, we cloned these two fusion proteins into
MSCV-Puro (Clontech). Guide sgRNAs were expressed using a lentiviral U6-
based expression vector derived from pSico, which coexpresses mCherry
from a CMV promoter. The sgRNA expression plasmids were cloned by insert-
ing annealed primers into the lentiviral U6-based expression vector that was
digested by BstXI and XhoI.
Cell Culture, DNA Transfections, and Fluorescence Measurements
for CRISPRi in Human Cells
HEK293 cells were maintained in Dulbecco’s modified Eagle medium (DMEM)
in 10% FBS, 2 mM glutamine, 100 units/ml streptomycin, and 100 mg/ml peni-
cillin. HEK293 were infected with a GFP-expressing MSCV retrovirus using
standard protocols and were sorted by flow cytometry using a BD FACS
Aria2 for stable GFP expression. GFP-expressing HEK293 cells were tran-
siently transfected using TransIT-LT1 transfection reagent (Mirus) with the
manufacturers recommended protocol in 24-well plates using 0.5 mg of the
dCas9 expression plasmid and 0.5 mg of the RNA expression plasmid (with
0.25 mg of GFP reporter plasmid for Figure S7). At 72 hr following transfection,
cells were trypsinized to a single cell suspension. The U6 vector contains
a constitutive CMV promoter driving an mCherry gene. GFP expression was
analyzed using a BD LSRII FACS machine by gating on the mCherry-positive
populations (>10-fold brighter mCherry over the negative control cells).
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